Effects of a 10 or 15 mg single intravenous bolus of ivabradine versus placebo on heart rate control during a multislice computed tomography coronary angiography for the evaluation of coronary artery disease. A randomised, double-blind, international, multi-centre study.

Trial Profile

Effects of a 10 or 15 mg single intravenous bolus of ivabradine versus placebo on heart rate control during a multislice computed tomography coronary angiography for the evaluation of coronary artery disease. A randomised, double-blind, international, multi-centre study.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Mar 2016

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Coronary artery disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Mar 2012 This trial is recruiting in United Kingdom, Spain and France.
    • 31 May 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
    • 13 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top